Solid Biosciences Inc. SLDB
NASDAQ · United States · Health Technology
$6.85-0.13 (-1.86%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.38 | -0.46 | +17.8% | $0 | — | -3.9%$8.73→$8.39 |
| Q1 2026 | 2026-05-12 | -0.52 | -0.40 | -30.0% | — | — | -3.9%$7.68→$7.38 |
| Q4 2025 | 2026-03-19 | -0.53 | -0.52 | -1.9% | — | — | -1.3%$7.12→$7.03 |
| Q3 2025 | 2025-11-03 | -0.48 | -0.44 | -9.1% | — | — | -18.3%$5.39→$4.41 |
| Q2 2025 | 2025-08-12 | -0.42 | -0.49 | +14.3% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.59 | -0.54 | -9.3% | — | — | — |
| Q4 2024 | 2025-03-06 | -1.00 | -0.78 | -28.2% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.61 | -0.66 | +7.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.